A radiology professor in France who plagiarized others’ work in a review article has resigned from his role as deputy editor of a medical journal amid new concerns about his publications, Retraction Watch has learned.
The professor, Romaric Loffroy of CHU Dijon Bourgogne, was first and corresponding author of the offending review, which included large amounts of text from two earlier papers without appropriate citation, as we reported last month.
When confronted with evidence of the plagiarism, Loffroy put the blame on an alleged undisclosed ghostwriter, then proceeded to tone down the offense, saying he wouldn’t mind it if his own work had been plagiarized.
Sampen, also a research professor at the University of Illinois-Chicago, said that “any errors that occurred involved discrete erroneously-placed figures or images” that “in no way undermine our basic conclusions and findings.”
Calling the episode a “long and hard battle for me,” Sampen sent us these comments:
A researcher who sued the publisher PLOS to prevent it from posting an expression of concern for one of her papers has dropped her suit, and the publisher tells us it will add a correction to the article instead – but may “revisit this case” to deal with “unresolved issues.”
We’ve previously reported on the lawsuit Soudamani Singh, an assistant professor in the Department of Clinical and Translational Sciences at Marshall University’s Joan C. Edwards School of Medicine in Huntington, W. Va., filed against PLOS in April, as well as signs of a pending settlement.
According to an order filed November 2, Singh informed the court that she “voluntarily dismisses” the claims in her complaint, without the possibility of re-filing them, and the judge dismissed the case.
A research biologist at the Jesse Brown Veterans Affairs Medical Center in Chicago faked images and inflated sample sizes in published papers and a grant application, the federal agency has determined.
Hee-Jeong Im Sampen, also a research professor of biomedical engineering at the University of Illinois, Chicago, “engaged in research misconduct by intentionally, knowingly and/or recklessly falsifying/fabricating data” in three published papers, an unpublished manuscript, a poster presentation, and a grant application for VA funding, according to a Federal Register notice.
Sampen, who publishes under the name Hee-Jeong Im, is corresponding author on all of the published papers the VA identified. The articles, which also list an affiliation with Rush University Medical Center, are:
At the beginning of February 2023, I discovered that the Scandinavian Journal of Information Systems (SJIS) had been hijacked. As editor-in-chief of the publication, I had been contacted by an author confused by receiving both an acceptance letter and a desk rejection for her manuscript. I had rejected the paper because it did not align with our editorial policy. Upon investigation, the acceptance letter turned out to have been issued by cybercriminals attempting to charge her for publication in what she thought was SJIS but was in fact a fraudulent website posing as the journal.
Journal hijacking is a growing problem and a threat to the entire scientific community. Hijacked journals are scam websites that impersonate legitimate journals and attempt to take over their brand. A list including hundreds of these fake sites can be found at the Retraction Watch Hijacked Journal Checker. By stealing the brand, web domain, or the serial number used to identify a publication, cybercriminals try to lure researchers into paying for publications. The problem is in part attributable to increased pressure on researchers to publish their work in journals indexed in Scopus, Elsevier’s abstract and citation database.
Researchers of all experience levels fall prey to such scams. This susceptibility often stems from the tendency to be off guard when communicating with seemingly authentic and trustworthy academic journals, particularly when links to these journals are found on otherwise credible bibliographical databases.
In the case that led to the discovery of the SJIS hijacking, the researcher who was swindled described the experience as harrowing, making her question whom she could trust. She also ran into trouble at her university, which required her to have two publications in Scopus-indexed journals to advance her career.
The publisher Sage has retracted 209 articles from an engineering journal after an investigation found “compromised peer review or 3rd party involvement,” according to a company spokesperson.
At that time, the company marked 318 additional papers “with more complex issues” with expressions of concern as it continued investigating. All of the papers retracted today previously had expressions of concern.
The 209 articles were retracted with five different notices. Some articles “contain indicators of third-party involvement” and the corresponding authors “were unable to provide a satisfactory explanation,” one read.
The director of one the nation’s premier cancer centers has been suspended amid concerns over several of his papers – but he tells Retraction Watch it is unrelated to comments about that work on PubPeer.
An email Wednesday to employees at New York University’s medical center – and a subsequent message to staff at the institution’s Perlmutter Cancer Center – explained that Benjamin Neel, the former director of the center, had been suspended.
The letter, signed by Steven Abramson, a rheumatologist and executive vice president at NYU Langone Health, did not state the reason for the move:
A paper touted as “the first systematic review and meta-analysis” of research on the effects of homeopathy for attention deficit and hyperactivity disorder (ADHD) has been retracted more than a year after critics first contacted the journal with concerns.
The article, “Is homeopathy effective for attention deficit and hyperactivity disorder? A meta-analysis,” appeared in Pediatric Research, a Springer Nature title, last June. It has not been cited in the scientific literature, according to Clarivate’s Web of Science, but Altmetric, which quantifies the online attention papers receive, ranks the paper in the top 5% of all articles ever tracked.
Individualized homeopathy showed a clinically relevant and statistically robust effect in the treatment of ADHD.
However, the retraction notice, dated September 20, detailed four “concerns regarding the analysis of the articles included in the meta-analysis,” and concluded:
Didier Raoult, the French infectious disease scientist who came to prominence for promoting hydroxychloroquine as a COVID-19 treatment, has lost two papers for ethics concerns after other scientists flagged issues with hundreds of publications from the institute he formerly led.
